AI-Enabled Scheduling Tool That Focuses Attention on Women Who Need Breast Screening the Most Nov. 29, 2021 – As many as 3.9 million women in the U.S. missed their routine mammograms due to the COVID-19 pandemic,* creating a significant backlog of women to be scheduled as breast screening clinics have re-opened with reduced capacity and…
Find out more
Collaboration leverages Stanford’s clinical expertise and Kheiron’s machine learning capabilities to assist radiologists in more effectively staging and monitoring treatment response of Non-Hodgkin’s Lymphoma Nov. 29, 2021 – Kheiron Medical Technologies today announced its new collaboration with researchers at Stanford University to design functional proof-of-concept deep learning models to solve clinical problems in novel ways,…
Find out more
Award-Winning AI Solutions Developer Launches Image Quality Assurance Tool to Support Radiographers and Radiologists in Breast Screening Process Nov. 29, 2021 – To aid breast screening providers in the improvement of image quality, training, and audit preparation, Kheiron Medical Technologies, an award-winning applied science company based in the United Kingdom, is introducing its Mia IQ™…
Find out more
“The study will provide evidence to help assess whether the use of AI in this instance could be a viable option,” said Dr William Teh, clinical lead with Royal Free London NHS Foundation Trust We are delighted to announce that Royal Free London NHS Foundation Trust have signed up to work with Kheiron Medical Technologies…
Find out more
Partnership marks significant step in the journey to build evidence base to demonstrate effectiveness and safety of AI in NHS breast cancer screening LONDON, 26 October 2021– Gateshead Health Foundation NHS Trust has entered into a research agreement with Kheiron Medical Technologies as part of the NHS Artificial Intelligence (AI) in Health & Care Award. The aim of the award…
Find out more
Kheiron Medical Technologies partners with Waleed Pharmacy & Stores to bring AI breast screening solution Mia® to Oman healthcare community Mia is the first and only AI-enabled independent reader for breast cancer screening to be commercially available in Oman Muscat, 22 October 2021 – Mia®, a deep learning artificial intelligence (AI) solution that works with…
Find out more
Our AI-enabled breast screening scheduling solution, RSViP, has been named a Minnies semifinalist for Best New Radiology Software.
Find out more
Our award for British Leader acknowledges our outstanding innovation, business scale and global impact.
Find out more
In 2020, more than 2.2 million cases of breast cancer were diagnosed. Kheiron Medical Company develops a platform for early cancer screening.
Find out more
Dr. Nisha Sharma discusses ‘Role of AI in Breast Screening’ at RANZCR New Zealand’s 2021 annual meeting.
Find out more